Primary Care Companion for CNS Disorders Primary Care Companion for CNS Disorders

The Primary
Care Companionfor CNS Disorders

Advancing primary care with essential peer-reviewed research and insights into CNS disorders

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Rounds in the General Hospital

PCC
Clozapine: Its Use and Monitoring
Rounds in the General Hospital

July 30, 2024

The authors provide the latest information on clozapine use, including when your patients should receive or avoid taking it, what laboratory tests are required before and during administration, and…
Desta S. Lissanu, Chirag M. Vyas, Carol S. Lim, et al
PCC
Pharmacologic Management of TBI
Rounds in the General Hospital

July 16, 2024

Cognitive complaints, including difficulties with attention, concentration, and memory, are common in patients post-TBI; however, many medications have been studied in the treatment of cognition after TBI. Read on…
Sofia E. Matta, Christina LaCroix, Kaloyan Tanev, et al
PCC
Evaluation and Management of Treatment-Resistant Schizophrenia
Rounds in the General Hospital

July 2, 2024

If you have ever been uncertain about how to evaluate patients with a chronic psychotic illness or struggled over how best to manage treatment-resistant schizophrenia, then this case vignette…
Carol S. Lim, Abigail L. Donovan, Chirag M. Vyas, et al
PCC
Neuropsychiatric Complications of Hypervitaminosis D
Rounds in the General Hospital

June 13, 2024

A 28-year-old man presented to the emergency department with severe agitation, insomnia, weakness, constipation, and muscle jerks after nonsuicidal overdosing of vitamin D.
James K. Rustad, Adam Z. Spitz, Brandon C. Wilson, et al
PCC
Impact of Disability on Medical Care
Rounds in the General Hospital

June 6, 2024

Given that many people have disabilities, physicians should develop skills that assess the level of disability, the functional consequence of illness, and the social and physical environments of patients…
Mirza Baig, Andrew S. Chun, Ashika Bains, et al
PCC
Management of Rumination and Obsessions in Primary Care
Rounds in the General Hospital

May 30, 2024

Difficult-to-control negative repetitive thoughts can manifest as ruminations or obsessions. Appropriate early identification and intervention can positively affect the course and prevent an episode of psychiatric illness.
Sharmin Ghaznavi, Charlotte Schiewe, Theodore A. Stern

Page 15

More PCC Articles

JCP
JCP’s New Look
Editorial

June 5, 2023

Editor in Chief Marlene P. Freeman introduces readers to JCP’s updates.
Marlene P. Freeman
JCP
Understanding 95% Confidence Intervals Around Relative Risk, Odds Ratio, and Hazard Ratio
Clinical and Practical Psychopharmacology

May 31, 2023

Dr Chittaranjan Andrade explains, in simple terms, an important concept: how to interpret 95% CIs for statistics expressed along an exponential scale.
Chittaranjan Andrade
JCP
Clinical Follow-Up and Widening LAI Intervals
Commentary

May 31, 2023

Although the administration intervals of long-acting injectable antipsychotics are a starting point for scheduling follow-ups, frequency of prescriber contact should be based on individual risk factors and real-world constraints.
Samuel J. Dotson, Robert O. Cotes, Oliver Freudenreich
JCP
Social Support and Symptoms of PTSD
Original Research

May 29, 2023

Social support affects the development and persistence of PTSD. A sense of belongingness to family and/or friends was associated with fewer PTSD symptoms in older adults.
Helene M. Altmann, Marie Anne Gebara, Steven M. Albert, et al
JCP
Use of Medication With Depressive Symptom Side Effects
Original Research

May 24, 2023

MDD patients who used non-psychiatric medications with depressive side effects had higher odds of experiencing moderate to severe depressive symptoms.
Ramin Mojtabai, Masoumeh Amin-Esmaeili, Stanislav Spivak, et al
JCP
Suicidal Ideation in Residential Substance Use Treatment
Original Research

May 22, 2023

People with substance use disorders (SUDs) and chronic health/psychiatric conditions may have higher risk for suicidal ideation than those with only SUD. Integrated treatments for patients with suicidal ideation…
Jennifer D. Ellis, Jill A. Rabinowitz, Justin C. Strickland, et al
JCP
Vortioxetine vs Desvenlafaxine in Patients With MDD
Original Research

May 22, 2023

Compared with desvenlafaxine, vortioxetine was associated with higher rates of symptomatic and functional remission, better daily and social functioning, and greater treatment satisfaction in patients with major depression and…
Roger S. McIntyre, Ioana Florea, Mads Møller Pedersen, et al
JCP
Predicting Remission From Depression in Youth Receiving Outpatient Medication Management
Original Research

May 17, 2023

Among 430 youth beginning treatment for depression, about one-quarter achieved remission within 6 months. The odds of remitting decreased as baseline symptom severity increased.
Kennedy M. Balzen, Jane K. Hensley, Paul A. Nakonezny, et al
JCP
Cardiac Malformation Risks After First Trimester Methylphenidate Use
Brief Report

May 15, 2023

This meta-analysis found that use of methylphenidate in the first trimester may be a risk factor for fetal congenital heart defects.
Jonathan L. Richardson, Nathan George, Amanda J. Greenall, et al
JCP
Research Participant Feedback on a Suicide Safety Protocol
Original Research

May 15, 2023

In women who triggered a safety protocol as part of a perinatal suicidal ideation study, 50% reported that the protocol increased engagement with treatment, and most reported a “positive…
Rachel Vanderkruik, Marlene P. Freeman, Katherine A. Dunn, et al
JCP
Control Conditions in Randomized Trials of Psychedelics: An ACTTION Systematic Review
Systematic Review

May 10, 2023

Randomized trials of psychedelics underutilize blind assessment, active drug controls, and testing psychological support against minimal-support conditions—elements that would improve quality or provide important information.
Sandeep M. Nayak, Melissa K. Bradley, Bethea A. Kleykamp, et al
JCP
Depression Treatment Response Beyond 50% Improvement
Original Research

May 8, 2023

Although most depression treatment research focuses on symptom improvement, patients have additional treatment priorities, including functioning, coping ability, and quality of life.
Mark Zimmerman, Sin-Ying Lin

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe